Blood tests could replace risky biopsies for transplant patients

This study is testing two blood tests (AlloSure and AlloMap) to see if they can detect organ rejection in people who have received both a kidney and pancreas transplant. The goal is to find a safer, non-invasive way to monitor transplant health instead of using risky organ biopsies. Researchers will follow 42 transplant patients to see if these blood tests can accurately spot early signs that either organ is being rejected by the body's immune system.